# US 2015/0305943 A1 · Devices and Methods for Treatment of the Eustachian Tube and Sinus Cavity

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0305943 A1
- Document ID: US20150305943A1
- Status: Published application
- Kind: A1
- Application number: 14/265,343
- Filed: 2014-04-29
- Published: 2015-10-29
- Earliest claimed: 2014-04-29
- Assignees: Abbott Cardiovascular Systems Inc.
- Applicants: Abbott Cardiovascular Systems Inc.
- Inventors: Syed Hossainy; Paul Consigny; Dariush Davalian; James Su; Michael Ngo; Adrain Gale; Jesus Magana; Mikael Trollsas; Evan Norton; Benjamyn Serna
- Web page: https://patentgrep.com/patent/US20150305943A1

## CPC

- A61F 2/958: Inflatable balloons for placing stents or stent-grafts
- A61B 1/06: with illuminating arrangements
- A61F 2/915: with bands having a meander structure, adjacent bands being connected to each other
- A61F 11/202: {Surgical middle-ear ventilation or drainage, e.g. permanent; Implants therefor}
- A61M 25/10: Balloon catheters ({A61M25/0125 takes precedence; embolectomy A61B17/22032; retractors A61B17/02;} inflatable balloons for placing stents or stent-grafts A61F2/958 {; stomach balloons for treatment of obesity A61F5/0003; oesophagal tubes A61J15/00})
- A61M 29/02: Dilators made of swellable material {(balloon catheters for angioplasty A61M25/104)}
- A61F 2002/91575: {connected peak to trough}
- A61F 2002/91583: {by a bridge, whereby at least one of its ends is connected along the length of a strut between two consecutive apices within a band}
- A61F 2230/0067: conical
- A61F 2250/0018: differing in elasticity, stiffness or compressibility
- A61F 2250/0026: differing in surface structures
- A61F 2250/0046: differing in melting temperature
- A61F 2250/0048: differing in mechanical expandability, e.g. in mechanical, self- or balloon expandability
- A61F 2250/005: differing in colour
- A61F 2250/0082: specially designed for children, e.g. having means for adjusting to their growth
- A61M 2025/105: {having a balloon suitable for drug delivery, e.g. by using holes for delivery, drug coating or membranes}
- A61M 2025/1059: {having different inflatable sections mainly depending on the response to the inflation pressure, e.g. due to different material properties}
- A61M 2210/0675: Eustachian tube
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}

## Abstract

A polymeric stent can be implanted for treatment of the Eustachian tube. The stent can be designed to have length-dependent radial strength to allow it to stay within the Eustachian tube and to allow normal closing and opening of the Eustachian tube. A balloon can be used to implant the stent, and the balloon can be coated with a therapeutic agent. A coated balloon can also be used to transfer therapeutic agents to the sinus cavity during a balloon sinus dilation procedure.

## Claims

### Claim 1

A polymeric stent for treating the Eustachian tube, the stent comprising:
a tubular scaffold configured for implantation in the Eustachian tube, the tubular scaffold having a polymer substrate, the tubular scaffold including a proximal segment and a distal segment, the proximal segment including radially deformable rings, the distal segment including radially deformable rings having a greater radial strength than the radially deformable rings of the proximal segment.

### Claim 2 (depends on 1)

The polymeric stent of claim 1, wherein discontinuities are present in the radially deformable rings of the proximal segment, each of the discontinuities are defined as a cut through a full width and a full thickness of the radially deformable ring in which the discontinuity is present, and discontinuities are absent from the radially deformable rings of the distal segment.

### Claim 3 (depends on 1)

The polymeric stent of claim 1, wherein one or more of the radially deformable rings of the distal segment have polymer molecules that have a preferential orientation that is less axial than that of the radially deformable rings of the proximal segment.

### Claim 4 (depends on 1)

The polymeric stent of claim 1, wherein one or more of the radially deformable rings of the distal segment have full widths that are greater than that of one or more of the radially deformable rings of the proximal segment.

### Claim 5 (depends on 1)

The polymeric stent of claim 1, wherein one or more of the radially deformable rings of the distal segment have full thicknesses that are greater than that of one or more of the radially deformable rings of the proximal segment.

### Claim 6 (depends on 1)

The polymeric stent of claim 1, wherein the polymer substrate of one or more of the radially deformable rings of the distal segment has a molecular weight greater than that of the polymer substrate of one or more of the radially deformable rings of the proximal segment.

### Claim 7 (depends on 1)

The polymeric stent of claim 1, wherein the polymer substrate includes a base component and a dopant having a lower elastic modulus than that of the base component, the base component is present at a higher percentage than the dopant in the polymer substrate of the radially deformable rings of the distal segment, and the dopant is present at a higher percentage than the base component in the polymer substrate of the radially deformable rings of the proximal segment.

### Claim 8 (depends on 1)

The polymeric stent of claim 1, wherein the polymer substrate of one or more radially deformable rings of the distal segment has at least one parameter greater than that of the polymer substrate of one or more radially deformable rings of the proximal segment, the at least one parameter being any one or more of: melt temperature, glass transition temperature, and percent crystallinity.

### Claim 9 (depends on 1)

The polymeric stent of claim 1, wherein one or more of the radially deformable rings of the distal segment have outer diameters that are greater than that of one or more of the radially deformable rings of the proximal segment.

### Claim 10 (depends on 1)

The polymeric stent of claim 1, wherein the tubular scaffold includes a plurality of stent marks, the stent marks are spaced equally apart from each other, and each of the stent marks has a characteristic that differentiates the stent mark from a portion of the tubular scaffold that is adjacent to the stent mark, and the characteristic is an opacity, a color, a shade, a shape, an alphanumeric character, or a combination thereof.

### Claim 11

A system for delivering a stent in the Eustachian tube, the system comprising:
a catheter including a body and a balloon at an end of the body, the balloon configured to carry a stent for delivery through a nasopharynx cavity and into a Eustachian tube of a patient.

### Claim 12 (depends on 11)

The system of claim 11, further comprising a stent mounted onto the balloon.

### Claim 13 (depends on 11)

The system of claim 11, further comprising a guidewire having an end segment sized for insertion into the Eustachian tube and a plurality of wire marks applied or etched on an exposed surface of the end segment, and the catheter includes a passageway configured to receive the guidewire.

### Claim 14 (depends on 13)

The system of claim 13, wherein each of the wire marks has a characteristic which distinguishes the wire mark from an adjacent wire mark, and the characteristic is a color, a shade, a shape, an alphanumeric character, or a combination thereof.

### Claim 15 (depends on 13)

The system of claim 13, wherein each of the wire marks is a band that encircles the end segment of the guidewire, and each band has an axial size that is at least 2 mm.

### Claim 16 (depends on 13)

The system of claim 13, wherein the end segment of the guidewire is configured to emit light.

### Claim 17 (depends on 13)

The system of claim 13, wherein the end segment of the guidewire includes a stabilization feature configured to expand and engage a surface of the Eustachian tube.

### Claim at position 18

18-21. (canceled)

### Claim 22

A catheter for treating the Eustachian tube or the sinus cavity, the catheter comprising:
a body;
a balloon at an end of the body, the balloon configured to pass into a sinus cavity or into a Eustachian tube of a patient; and
a coating on the balloon, the coating including at least one therapeutic agent.

### Claim at position 20

23-33. (canceled)

### Claim 34

A method of treating a Eustachian tube with a stent, the method comprising:
placing a stent in a Eustachian tube of a patient.

### Claim at position 22

35-42. (canceled)

### Claim 43

A method of treating a Eustachian tube or sinus cavity with a balloon, the method comprising:
inflating a balloon in a Eustachian tube or a sinus cavity of a patient; and
allowing at least one therapeutic agent to transfer from the inflated balloon to a wall of the Eustachian tube or the sinus cavity.

### Claim at position 24

44-50. (canceled)
